| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 6 |
| 1 | RISANKIZUMAB-RZAA | 4 |
| 2 | ADALIMUMAB | 3 |
| 3 | FULVESTRANT | 3 |
| 4 | METHOTREXATE SODIUM | 3 |
| 5 | UPADACITINIB | 3 |
| 6 | AFLIBERCEPT | 2 |
| 7 | ASPIRIN | 2 |
| 8 | ASPIRIN 325 MG | 2 |
| 9 | ASPIRIN 81 MG | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LEBRIKIZUMAB-LBKZ | 1 | 0.0004 |
| 1 | VUTRISIRAN | 1 | 0.0003 |
| 2 | ALOGLIPTIN | 1 | 0.0003 |
| 3 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 4 | FARICIMAB | 2 | 0.0002 |
| 5 | ZANUBRUTINIB | 1 | 0.0002 |
| 6 | TEPROTUMUMAB | 1 | 0.0002 |
| 7 | PENTOSAN POLYSULFATE SODIUM | 1 | 0.0001 |
| 8 | QUINAPRIL HYDROCHLORIDE | 1 | 0.0001 |
| 9 | BINIMETINIB | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |
| 2 | Interleukin-13 Antagonist [EPC] | 1 | 0.0001 |
| 3 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 4 | Estrogen Receptor Antagonist [EPC] | 3 | 0.0001 |
| 5 | Radioligand Therapeutic Agent [EPC] | 1 | 0.0001 |
| 6 | Progesterone [EPC] | 1 | 0.0000 |
| 7 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 1 | 0.0000 |
| 8 | Interleukin-23 Antagonist [EPC] | 4 | 0.0000 |
| 9 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |